Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Tagrisso
DRUG
3 trials
Sponsors
Shaare Zedek Medical Center
, Seoul National University Hospital
, Suzhou Genhouse Bio Co., Ltd.
Conditions
Locally Advanced or Metastatic NSCLC
Lung Cancer, Non-small Cell
Non-Small Cell Lung Cancer With EGFR Mutation
Phase 1
A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC
Recruiting
NCT06306456
Suzhou Genhouse Bio Co., Ltd.
Non-Small Cell Lung Cancer With EGFR Mutation
Start: 2024-03-05
End: 2026-12-31
Target: 94
Updated: 2024-07-08
Phase 2
Neo-adjuvant Trial With AZD9291 in EGFRm+ Stage IIIA/B NSCLC
NCT02824952
Shaare Zedek Medical Center
Lung Cancer, Non-small Cell
Start: 2018-11-01
End: 2022-12-31
Target: 40
Updated: 2021-11-18
Unknown Phase
Whole Genomic Landscape of Advanced EGFR-mutant NSCLC
Active, not recruiting
NCT03969823
Seoul National University Hospital
Locally Advanced or Metastatic NSCLC
Start: 2019-05-23
End: 2025-12-31
Target: 148
Updated: 2025-05-15